Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 994-998

  Cuzzola, Maria ^a   Mancuso, Giuseppe ^a   Beninati, Concetta ^a   Biondo, Carmelo ^a   Von Hunolstein, Christina ^b   Orefici, Zraziella ^b   Espevik, Terje ^c   Flo, Trude H ^c   Teti, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; CYTOKINE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MONOCLONAL ANTIBODY; POLYMYXIN B; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANIMALS; ANTIGENS, CD14; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE-1 ANTIGEN; MICE; MONOCYTES; POLYSACCHARIDES, BACTERIAL; RECEPTORS, TUMOR NECROSIS FACTOR; STREPTOCOCCUS AGALACTIAE; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033979232     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.994-998.2000     Document Type: Article

References (36)

1. Alkan, M. L., and E. Beachey. 1978. Excretion of lipoteichnic acid by group A streplococci. J. Clin. Investig. 61:671-677.
2. Baker, C. J. 1986. Group B streptococcal infections in newborns. N. Engl. J. Med. 314:1702-1708.
3. Bone, R. C. 1994. Gram positive organisms and sepsis. Arch. Intern. Med. 154:26-34.
4. Carey, R. B., T. K. Eisenstein, G. D. Shockman, T. F. Greber, and R. M. Swenson. 1980. Soluble group- and type-specific antigens from type III group B Streptococcus. Infect. Immun. 28:195-203.
5. Chaka, W., A. F. M. Verheul, V. V. Vaishnav, R. Cherniak, J. Scharringa, J. Verhoef, H. Snippe, and A. I. M. Hoepelman. 1997. Induction of TNF-α in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J. Immunol. 159:2979-2985.
6. Cleveland, M. G., J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy. 1996. Lipoteichoic acid preparation of gram-positive bacteria induce interleukin-12 throughout a CD14-dependent pathway. Infect. Immun. 64:1906-1912.
7. Cusumano, V., F. Genovese, G. Mancuso, M. Carbone, M. T. Fera, and G. Teti. 1996. Interleukin-10 protects neonatal mice from lethal group B streplococcal infection. Infect. Immun. 64:2850-2852.
8. Delfino, D., L. Cianci, E. Lupis, A. Celeste, M. L. Petrelli, F. Currò, V. Cusumano, and G. Teti. 1997. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect. Immun. 65: 2454-2456.
9. Delude, R. L., R. Savedra, H. Zhao, R. Thierienger, S. Yamomoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288-9292.
10. Doran, T, I., and S. I. Mattingly. 1982. Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus. Infect. Immun. 36:1115-1122.
11. Edwards, M. S., and C. J. Baker. 1979. Prospective diagnosis of early onset group B streptococcal infection by countercurrent immunoelectrophoresis. J. Pediatr. 94:286-288.
12. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
13. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Mcd. 176:1665-1671.
14. Gazzano-Santoro, H., J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon. 1992. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60:4754-4761.
15. Givner, L. B., L. Gray, and T. M. O'Shea, 1995. Antibodies to tumor necrosis factor-α: use and adjunctive therapy in established group B streptococcal disease m newborn rats. Pediatr, Res. 38:551-554.
16. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271: 23310-23319.
17. Hattor, Y., K. Kasai, K. Akimoto, and C. Thiemermann. 1997. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CDM-dependent pathway. Biochem. Biophys. Res. Commun. 233:375-381.
18. Jahr, T. G., L. Ryan, A. Sundan, H. S. Lichenstein, G. Skjak-Braek, and T. Espevik. 1997. Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bacterial/permeability-increasing factor. Infect. Immun. 65:89-94.
19. Mancuso, G., F. Tomasello, M. Migliardo, D. Delfino, J. Cochran, J. A. Cook, and G. Teti. 1994. Beneficial effects of interleukin-6 in neonatal models of group B streptococcal disease. Infect. Immun. 62:4992-5002.
20. Mancuso, G., F. Tomasello, I. Ofek, and G. Teti. 1994. Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect. Immun. 62:1470-1473.
21. Mancuso, G., F. Tomasello, C. von Hunolstein, G. Orefici, and G. Teti. 1994. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect. Immun. 62:2748-2753.
22. Mathison, J. C., P. S. Tobias, E. Wolfson, and R. J. Ulevitch. 1992. Plasma lipopolysaccharidc (LPS)-binding protein. A key component in macrophage recognition of gram-negative bacteria. J. Immunol. 149:200-206.
23. Medvedev, A. E., T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, and T. Espevik. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160: 4535-4542.
24. Teti, G., M. Calapai, G. Calogero, F. Tomasello, G. Mancuso, A. Galli, and G. Riggio. 1992. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Hybridoma 11:13-22
25. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-235.
26. Teti, G., F. Tomasello, M. S. Chiofalo, G. Orefici, and P. Mastroeni. 1987. Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. Infect. Immun. 55:3057-3064.
27. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
28. Vallejo, J. G., C. L. Baker, and M. S. Edwards. 1996. Inlerleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J. Infect. Dis. 174:332-337.
29. Vallejo, J. G., C. J. Baker, and M. S. Edwards. 1996. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect. Immun. 64:5042-5046.
30. von Hunolstein, C., A. Tutolian, G. Alfarone, G. Mancuso, V. Cusumano, G. Teti, and G. Orefici. 1997. Soluble antigens from group B streptococci induce cytokine production in human blood cultures. Infect. Immun. 65:4017-4021.
31. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H. D. Flad, and A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709-4715.
32. Weidemann, B., J. Schletter, R. Dziarski, S. Kusumoto, F. Stelter, E. T. Rietschel, H. D. Flad, and A. J. Ulmer. 1997. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect. Immun. 65:858-864.
33. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431-1433.
34. Yoshimura, A., E. Lien, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. lmmunol. 163:1-5.
35. Zarewych, D. M., A. L. Kindzelskii, R. F. Todd III, and H. R. Petty. 1996. LPS induces CD14 association with complement receptor type 3, which is reserved by neutrophil adhesion. J. lmmunol. 156:430-433.
36. Ziegler-Heitbrock, H. W. L., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-125.